NCT05191732View on ClinicalTrials.gov

Effect of PRP Versus BMC in Anterior Cruciate Ligament Reconstruction

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

July 4, 2020

Study Completion Date

July 4, 2020

Conditions
Anterior Cruciate Ligament Reconstruction
Interventions
COMBINATION_PRODUCT

Platelet-Rich Plasma; Bone marrow concentrate

Platelet-rich plasma (PRP) (Dosage form: APA-15) Bone marrow concentrate (BMC) (Dosage form: APA-15Q)

Trial Locations (1)

807

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Ministry of Health and Welfare, Taiwan

OTHER_GOV

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT05191732 - Effect of PRP Versus BMC in Anterior Cruciate Ligament Reconstruction | Biotech Hunter | Biotech Hunter